Skip to main content

Advertisement

Table 4 Resource consumption per patient, during each 4 weeks, by HAM-A score

From: A cost-utility analysis of pregabalin versus venlafaxine XR in the treatment of generalized anxiety disorder in Portugal

  HAM-A Score
≤ 9 10 - 15 16 - 24 ≥ 25
Number of doctor visits
  Number of general practitioner visits 0.6 0.8 1.2 1.6
  Number of psychiatrist visits 0.08 0.1 0.2 0.4
  Number of other specialist visits 0.15 0.2 0.3 0.4
Number of psychologist visits 0 0 0.1 0.1
Number of emergency attendances 0.05 0.1 0.15 0.25
Number of exams and analyses
  Number of electrocardiograms 0.3 0.4 0.6 0.8
  Number of blood analyses 0.3 0.4 0.6 0.8
  Number of thyroid functions 0 0 0.05 0.05
Number of inpatient stays 0 0 0 0.004
Concomitant drugs for both alternatives
  Proportion taking antipsychotics 0% 0% 5% 10%
  Most prescribed Quetiapine
  Mean daily dose - - 100 mg qd 100 mg qd
  Proportion taking hypnotics 0% 0% 10% 20%
  Most prescribed Zolpidem
  Mean daily dose - - 10 mg qd 10 mg qd
Concomitant drugs for venlafaxine XR
  Proportion taking anxiolytics 100% 100% 100% 100%
  Most prescribed Alprazolam
  Mean daily dose 0.5 mg qd 0.5 mg qd 0.5 mg tid 1 mg tid
Concomitant drugs for pregabalin
  Proportion taking antidepressants 10% 25% 50% 50%
  Most prescribed Paroxetine
  Mean daily dose 10 mg qd 10 mg qd 20 mg qd 20 mg qd
  1. Source: Expert panel.
  2. Blood analyses include glucose, gamma glutamyl transferase, creatinine, haemogram, sedimentation velocity, aspartate and alanine aminotransferase, urea and urinalysis.